Shortage of 0.9% Sodium Chloride Injection USP
Areazine synthesizes this Health Canada drug-shortage notice directly from Drug Shortages Canada's official public data feed. See our methodology for full source attribution and refresh cadence.
An active shortage of 0.9% Sodium Chloride Injection USP has been reported, with no specific details on manufacturers or reasons available.
What this Health Canada drug-shortage notice tells you, and what most readers miss
This notice was issued by Drug Shortages Canada on April 7, 2026 and geographically references United States. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - Drug Shortages - determines the regulatory framework behind it, which shapes what mitigations (alternative therapies, allocation timelines, manufacturer guidance) are available and which agency holds oversight.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are drug-shortage, fda, medication, 0.9%SODIUMCHLORIDEINJECTIONUSP.
Shortage of 0.9% Sodium Chloride Injection USP
Areazine reports on the current drug shortage based on available data. This medication is essential for many, and we aim to provide clear information without causing alarm.
What's in Shortage
The drug in shortage is 0.9% Sodium Chloride Injection USP. This is an active shortage, but specific details on dosage form, strength, or therapeutic category are not provided in the available data.
Which Manufacturers Are Affected
No manufacturers are listed as affected in the source data, so availability status and contact information are not available.
Why There's a Shortage
No specific reason for the shortage has been provided in the source data.
What Patients Should Do
Patients who rely on this medication should talk to their pharmacist or healthcare provider for guidance. They can also ask about potential alternatives, though no specific options are suggested here. Remember, patients should consult their healthcare provider for any medical advice or changes to their treatment.
Source
This information is attributed to the FDA Drug Shortage Database.
Original source: Drug Shortages Canada Official Notice ↗
Related Drug Shortages
All Drug Shortages →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this Health Canada drug-shortage notice: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,128 characters here).
Similar severity timing
Same severity (high) notices issued closest in time to April 7, 2026.
Frequently Asked Questions
Common questions about this Health Canada drug-shortage notice.